PMV Pharmaceuticals/$PMVP

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About PMV Pharmaceuticals

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Ticker

$PMVP
Sector
Health
Primary listing
NASDAQ

Employees

54
Headquarters
Princeton, United States
Website
www.pmvpharma.com

PMVP Metrics

BasicAdvanced
$60m
-
-$1.48
-
-

What the Analysts think about PMVP

Analyst ratings (Buy, Hold, Sell) for PMV Pharmaceuticals stock.

PMVP Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37bn
-39.75%
Net income
$45bn
107.52%
Profit margin
37.65%
6.78%

PMVP Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PMVP

Sign up or log in to buy
Capital at risk
Market closedLow-cap

Upcoming events

No upcoming events
FAQs